MPS Pharmaa Ltd.

BSE: 531686

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

2.08+0.0 (+0.00%)

19 Oct, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

MPS Pharmaa Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2002	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	—	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	Mar Jun	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Presentations	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Corporate Announcements and Regulatory Filings

MPS Pharmaa Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

General10 Oct 2026
Statement Of Investor Complaints For The Quarter Ended 30Thseptember, 2026
PFA Statement of Investor Complaints for the Quarter ended 30th September , 2026
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Oct 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Certificate u/r 74(5) of SEBI (DP) Regulations, 2018 for the quarter and half year ended 30th September, 2026
Change in Directorate1 Oct 2026
Announcement under Regulation 30 (LODR)-Change in Directorate
PFA Outcome of 32nd Annual General Meeting of the Company held on 29th September, 2026
Appointment of Statutory Auditor/s1 Oct 2026
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
PFA Outcome of 32nd Annual General Meeting of the Company held on 29th September, 2026
Appointment of Statutory Auditor/s1 Oct 2026
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
PFA Outcome of 32nd Annual General Meeting of the Company held on 29th September, 2026
Change in Management1 Oct 2026
Announcement under Regulation 30 (LODR)-Change in Management
PFA Outcome of 32nd Annual General Meeting of the Company held on 29th September, 2026
General1 Oct 2026
Outcome Of The 32Nd Annual General Meeting Of The Company Held On Tuesday 29Th September, 2026
Please find attached outcome of 32nd Annual General Meeting of the Company held on Tuesday, 29th September, 2026
General1 Oct 2026
Outcome Of The 32Nd Annual General Meeting Of The Company Held On Tuesday 29Th September, 2026
Please find attached outcome of 32nd Annual General Meeting of the Company held on Tuesday, 29th September, 2026
AGM1 Oct 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Submission of Voting Results of the 32nd Annual General Meeting of the Company.
AGM29 Sept 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome and Proceedings of 32nd AGM of the Company held on 29th September, 2026
Closure of Trading Window26 Sept 2026
Closure of Trading Window
Intimation of Closure of Trading Window
Closure of Trading Window26 Sept 2026
Closure of Trading Window
Intimation of Closure of Trading Window
Book Closure7 Sept 2026
Notice Of Book Closure
PFA notice of Book Closure pursuant to Regulation 42 of the SEBI (LODR) Regulations, 2015
Book Closure7 Sept 2026
Notice Of Book Closure
PFA Notice of Book Closure pursuant to Regulation 42 of the SEBI (LODR) Regulations, 2015
Newspaper Publication6 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication w.r.t 32nd AGM, Book Closure Notice and Remote Evoting Information
AGM5 Sept 2026
Notice Of The 32Nd Annual General Meeting For The Financial Year 2025-26
Notice of the 32nd Annual General Meeting for the Financial Year 2025-26
General5 Sept 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Web Link, QR Code And Navigation Path For Accessing The Annual Report For FY 2025-26
Intimation under Regulation 30 of the SEBI (LIsting Obligations and Disclosure Requirements) Regulations, 2015- Web Link, QR COde and Navigation Path for Accessing the Annual Report for the FY 2025-26
Reg. 34 (1) Annual Report5 Sept 2026
Reg. 34 (1) Annual Report.
Submission of Annual Report for the Financial Year 2025-2026
Change in Management2 Sept 2026
Announcement under Regulation 30 (LODR)-Change in Management
Reccomendation of Appointment of Ms. Anchal Goyal as an Independent Director of the Company. Reccomendation of Re- appointment of M/s. Nemani Garg Agarwal & Co. Firm as Statutory Auditors ....
Appointment of Statutory Auditor/s2 Sept 2026
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Appointment of M/s. Nemani Garg Agarwal & Co. as the Statutory Auditors of the Company

Frequently Asked Questions

Where can I download the annual report of MPS Pharmaa Ltd.?

Annual reports of MPS Pharmaa Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of MPS Pharmaa Ltd.?

Quarterly earnings results and presentations of MPS Pharmaa Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does MPS Pharmaa Ltd. publish earnings call transcripts?

Earnings call transcripts of MPS Pharmaa Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of MPS Pharmaa Ltd.?

Investor presentations and annual day presentations of MPS Pharmaa Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of MPS Pharmaa Ltd.?

Corporate announcements and regulatory filings of MPS Pharmaa Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of MPS Pharmaa Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of MPS Pharmaa Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of MPS Pharmaa Ltd.?

The ISIN (International Securities Identification Number) of MPS Pharmaa Ltd. is INE537C01019. This is the unique identifier used across exchanges and depositories.

On which stock exchange is MPS Pharmaa Ltd. listed?

MPS Pharmaa Ltd. is listed on NSE and BSE. The NSE symbol is ADVIKLA and the BSE code is -.

Where can I find the shareholding pattern of MPS Pharmaa Ltd.?

The quarterly shareholding pattern of MPS Pharmaa Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for MPS Pharmaa Ltd. on Sharpely?

Share price data for MPS Pharmaa Ltd. is updated as of 19 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.